On May 25, 2023, Salarius Pharmaceuticals, Inc. closed the transaction. The transaction included participation from a single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4951 USD | -0.78% | +0.41% | -23.83% |
Mar. 25 | Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data | MT |
Mar. 25 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.83% | 2.14M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SLRX Stock
- News Salarius Pharmaceuticals, Inc.
- Salarius Pharmaceuticals, Inc. announced that it has received $6.000001 million in funding